Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating Tarceva (erlotinib) after platinum-based chemotherapy in patients with advanced, recurrent, or metastatic non-small…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial assessing the safety and efficacy of a combination of Carboplatin, Paclitaxel, Bevacizumab, and CA4P in non-small cell lung ca…
-
CLINICAL_TRIALS research · 2015-02-06Clinical Trial Update: Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)
A completed clinical trial evaluating detection of chromosomal aberrations in non-small cell lung cancer using Fluorescent in Situ Hybridiza…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This update covers a Phase 2 trial of zoledronic acid plus PET imaging in advanced non-small cell lung cancer, which was terminated and has …
-
CLINICAL_TRIALS research · 2015-02-03Clinical Trial Update: MRI Optimization Study in Stage III NSCLC
This document provides an update on an MRI optimization study for patients with stage III non-small cell lung cancer conducted by UMC Utrech…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer
A clinical trial update on video-assisted thoracoscopic surgery (VATS) major lung resection for Chinese patients with early-stage non-small …
-
CLINICAL_TRIALS research · 2015-01-27Clinical Trial Update: Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC)
Clinical trial update describing a modified Video-assisted Thoracoscopic Surgery (VATS) lobectomy approach for early-stage non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing afatinib (BIBW 2992) to gemcitabine-cisplatin in first-line non-small cell lung cancer has completed with results po…
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) [Phase 2, Phase 3]
An ongoing comparator-controlled trial (BROKE) is testing EGFR-mutant non-small cell lung cancer patients with multiple brain metastases in …
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC
This clinical trial update reports an ongoing study evaluating a combination of recombinant human thrombopoietin (rHuTPO) and recombinant hu…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) [Phase 1]
Phase 1 dose-escalation study evaluating oral BIBF 1120 in combination with intravenous carboplatin and vinorelbine in elderly patients with…
-
CLINICAL_TRIALS withdrawal · 2015-01-21Clinical Trial Update: A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1) [Phase 2]
A phase 2 study of ridaforolimus in KRAS-mutant non-small cell lung cancer sponsored by Merck Sharp & Dohme was terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients [Phase 3]
A Phase 3 trial comparing IMN1207 to casein in non-small cell lung cancer was terminated; the update does not report trial results.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. [Phase 3]
Phase 3 trial evaluating fusidic acid (Verutex), erythromycin (Eritex), and Fisiogel for management of Tarceva-associated rash in non-small …
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 study evaluating carboplatin, paclitaxel, and selenomethionine with radiation therapy for Stage III non-small cell lung cancer that …
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer [NA]
This clinical trial update reports results from a study evaluating the use of FDG-PET imaging during radiation therapy for non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]
Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), g…
-
CLINICAL_TRIALS withdrawal · 2015-01-12Clinical Trial Update: A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer [Phase 2]
Pfizer-sponsored Phase 2 study for patients with advanced EGFR-mutant non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors [Phase 1]
Phase 1 study evaluating the combination of MGCD0103 and docetaxel in advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of MGCD265 in combination with erlotinib or docetaxel in patients with advanced malignancies, including non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of eribulin mesylate (E7389) in recurrent or stage IIIB/IV non-small cell lung cancer has completed, and results were posted.
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung [Phase 3]
A Phase 3 trial comparing crizotinib to pemetrexed-platinum chemotherapy in patients with ALK-positive non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC [Phase 2]
Phase II trial of dasatinib in previously treated advanced non-small cell lung cancer was terminated, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE
Observational study evaluating erlotinib as second-line treatment in patients with squamous cell non-small cell lung cancer and wild-type EG…